We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical de... read more Featured Products: More products

Download Mobile App





Bracco Diagnostics Unveils Contrast Media and Device Offerings at RSNA 2019

By MedImaging International staff writers
Posted on 05 Dec 2019
Print article
Image: Multihance Contrast Media (Photo courtesy of Bracco Diagnostics Inc.)
Image: Multihance Contrast Media (Photo courtesy of Bracco Diagnostics Inc.)
Bracco Diagnostics Inc. (Monroe Township, N.J., USA), the US subsidiary of Bracco Imaging S.p.A., highlighted its full scope of offerings and advancements with its diagnostic imaging services and solutions portfolio at the 2019 RSNA Annual Meeting held December 1–6 in Chicago, USA.

Bracco Imaging develops, manufactures, and markets diagnostic imaging agents and solutions that meet medical needs. Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities, including X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers. The diagnostic imaging portfolio is completed by a range of medical devices and advanced administration systems for contrast imaging products.

At RSNA 2019, Bracco Diagnostics highlighted its focus on patient care and the power of choice, giving customers the ability to assess each patient's personal needs and decide upon the best contrast media option for their patients, whether the contrast is for an MRI, X-ray/CT, Ultrasound, or Nuclear Medicine examination. The company also stated its commitment towards smart solutions and innovative technologies to improve workflow, optimize image quality, and maximize efficiency. Bracco Diagnostics expressed its dedication and passion for funding education for the medical community with comprehensive, convenient programs tailored to address today's health care challenges. It offered interactive carousels for RSNA attendees to explore the company’s offerings and clinical breakthroughs to improve outcomes.

"We come to this year's RSNA eager to discuss the science of imaging with our customers and our industry partners," said Cosimo De Pinto, Vice President of Marketing at Bracco. "To say the next few years are going to be transformational would be an understatement. The balance of providing value-based care while riding the wave of technology and innovation can be daunting for our customers, but we believe we are in a unique position at Bracco to support both endeavors. It's an exciting time to be in the field of diagnostic imaging."

Related Links:
Bracco Diagnostics Inc.

Digital Radiographic System
OMNERA 300M
Portable Color Doppler Ultrasound Scanner
DCU10
Opaque X-Ray Mobile Lead Barrier
2594M
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Print article

Channels

Ultrasound

view channel
Image: The novel method of fighting cancer can stimulate critical cytokine secretion in T cells

Ultrasound-Directed Microbubbles Boost Immune Response Against Tumors

A significant challenge in cancer treatment is the tumor's ability to suppress the immune system, particularly by deactivating T cells that enter the tumor. Once inside, the tumor can inhibit T cells from... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.